ECP 2024 Final Programme

E-Posters 127 ECP 2024 Florence E-PS-02 013 Refining the pathologic features of invasive pleomorphic lobular carcinoma: a comprehensive study Irene Blázquez Muñoz, Spain J. Bosch, J. Azcarate, A. Petit, E. Guerra, A. Gumà, S. Pernas, M. Garcia Tejedor, M. Soler 014 Complete pathological response to neoadjuvant chemotherapy and its impact on breast cancer outcomes Ons Boudaouara, Tunisia W. Ben Makhlouf, M. Bouhamed, S. Graja, S. Charfi, T. Sellami Boudawara, W. Ben Kridis 015 Predictors of complete pathological response to neoadjuvant chemotherapy in patients with HER2 overexpressing breast cancer Ons Boudaouara, Tunisia W. Ben Makhlouf, S. Makni, M. Mellouli, W. Ben Kridis, T. Sellami Boudawara, C. Chaari 016 Comparison of pathological parameters, hormone receptor, Cerbb2 and Ki67 profile before and after neoadjuvant chemotherapy in breast cancer Gokce Hande Cavus, Turkey T. Ozturk, C. Turker Saricoban 017 A comparative analysis of E-cadherin expression in invasive lobular carcinoma, in situ carcinoma and normal breast epitheli- um Amalia-Georgiana Cernat-Stefan, France L. Djerroudi, A. Vincent-Salomon 018 Periductal stromal tumour: a case report of the 22nd case in the literature Dorra Chiba, Tunisia O. Bado, H. Hamchi, I. Bahri, W. Mokni, S. Bentekaya, B. Sriha, M. Mokni 019 Invasive breast carcinoma with osteo- clast-like stromal giant cells: a case report on a rare breast tumour type Nuno Chiote, Portugal S. Neves, A. Rodrigues, J. Vizcaíno, N. Jorge Lamas 020 Can sentinel lymph node (SLN) total tumour load (TTL) assessment by one-step nucleic acid amplification (OSNA) assay assist in the decision for additional axillary surgery in breast cancer patients after primary systemic treatment (PST)? Ana Rita Coelho, Portugal P. Pontes, A. Marques, B. Peleteiro, I. Amendoeira 023 A new case of tall cell carcinoma with reversed polarity Alicia Córdoba, Spain L. Ruiz, R. Beloqui, I. Amat, D. Guerrero 024 Pleomorphic adenoma of the breast Alba Diez Fernández, Spain M. Martinez Lopez 025 The comparative analysis of metaplastic breast carcinoma and triple negative breast carcinoma for prognosis and survival outcomes Omer Faruk Dilbaz, Turkey R. Ucak, C. Tanik, F. Kabukcuoglu 029 Cancer to cancer metastasis: a rare case of occult breast cancer metastasis into lung adenocarcinoma Afaf Elhag, United Kingdom O. Busari, E. Khalifa, A. Rahman 030 Optimizing breast screening reporting: insight from a hospital audit Aya Elmahs, United Kingdom 031 The relationship between HER2 immuno- histochemical staining patterns and treatment response in breast cancer Melis Erdal Cesur, Turkey F. Aker 033 Breast metachronous primary angiosarco- ma Sonia García-Fuertes, Spain N. Franco Rubio, E. Ponce Casas, R. Vilorio, E. Mejia, C. del Agua Arias-Camisón, M. Cardiel García